Cargando…
Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
Messenger RNA (mRNA)-based vaccines have shown promise against infectious diseases and several types of cancer in the last two decades. Their promise can be attributed to their safety profiles, high potency, and ability to be rapidly and affordably manufactured. Now, many RNA-based vaccines are bein...
Autores principales: | Alfagih, Iman M., Aldosari, Basmah, AlQuadeib, Bushra, Almurshedi, Alanood, Alfagih, Mariyam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823281/ https://www.ncbi.nlm.nih.gov/pubmed/33396817 http://dx.doi.org/10.3390/pharmaceutics13010045 |
Ejemplares similares
-
Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
por: Aldosari, Basmah N., et al.
Publicado: (2021) -
Development and Validation of a Simple and Sensitive LC-MS/MS Method for Quantification of Metformin in Dried Blood Spot Its Application as an Indicator for Medication Adherence
por: ALquadeib, Bushra T, et al.
Publicado: (2021) -
New investigation of anti-inflammatory activity of Polycladia crinita and biosynthesized selenium nanoparticles: isolation and characterization
por: Almurshedi, Alanood S., et al.
Publicado: (2023) -
Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment
por: Almurshedi, Alanood S, et al.
Publicado: (2021) -
A Novel Sustained Anti-Inflammatory Effect of Atorvastatin—Calcium PLGA Nanoparticles: In Vitro Optimization and In Vivo Evaluation
por: Abdelkader, Dalia H., et al.
Publicado: (2021)